Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 3
1947 1
1949 2
1950 1
1951 1
1955 1
1956 1
1958 1
1960 1
1961 1
1962 2
1963 1
1966 4
1967 2
1968 2
1969 2
1971 3
1975 1
1977 1
1978 2
1987 1
1988 1
1990 1
1991 1
1992 2
1993 2
1994 2
1995 1
1996 4
1997 2
1998 3
1999 5
2000 4
2001 7
2002 6
2003 7
2004 6
2005 3
2006 7
2007 8
2008 11
2009 11
2010 6
2011 11
2012 11
2013 6
2014 14
2015 13
2016 10
2017 10
2018 7
2019 10
2020 28
2021 25
2022 14
2023 13
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

283 results

Results by year

Filters applied: . Clear all
Page 1
Myoglobinuria.
David WS. David WS. Neurol Clin. 2000 Feb;18(1):215-43. doi: 10.1016/s0733-8619(05)70187-0. Neurol Clin. 2000. PMID: 10658177 Review.
Oral and Topical Treatment of Painful Diabetic Polyneuropathy: Practice Guideline Update Summary: Report of the AAN Guideline Subcommittee.
Price R, Smith D, Franklin G, Gronseth G, Pignone M, David WS, Armon C, Perkins BA, Bril V, Rae-Grant A, Halperin J, Licking N, O'Brien MD, Wessels SR, MacGregor LC, Fink K, Harkless LB, Colbert L, Callaghan BC. Price R, et al. Among authors: david ws. Neurology. 2022 Jan 4;98(1):31-43. doi: 10.1212/WNL.0000000000013038. Neurology. 2022. PMID: 34965987
Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
Wainger BJ, Macklin EA, Vucic S, McIlduff CE, Paganoni S, Maragakis NJ, Bedlack R, Goyal NA, Rutkove SB, Lange DJ, Rivner MH, Goutman SA, Ladha SS, Mauricio EA, Baloh RH, Simmons Z, Pothier L, Kassis SB, La T, Hall M, Evora A, Klements D, Hurtado A, Pereira JD, Koh J, Celnik PA, Chaudhry V, Gable K, Juel VC, Phielipp N, Marei A, Rosenquist P, Meehan S, Oskarsson B, Lewis RA, Kaur D, Kiskinis E, Woolf CJ, Eggan K, Weiss MD, Berry JD, David WS, Davila-Perez P, Camprodon JA, Pascual-Leone A, Kiernan MC, Shefner JM, Atassi N, Cudkowicz ME. Wainger BJ, et al. Among authors: david ws. JAMA Neurol. 2021 Feb 1;78(2):186-196. doi: 10.1001/jamaneurol.2020.4300. JAMA Neurol. 2021. PMID: 33226425 Free PMC article. Clinical Trial.
Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial.
Howard JF Jr, Nowak RJ, Wolfe GI, Freimer ML, Vu TH, Hinton JL, Benatar M, Duda PW, MacDougall JE, Farzaneh-Far R, Kaminski HJ; Zilucoplan MG Study Group; Barohn R, Dimachkie M, Pasnoor M, Farmakidis C, Liu T, Colgan S, Benatar MG, Bertorini T, Pillai R, Henegar R, Bromberg M, Gibson S, Janecki T, Freimer M, Elsheikh B, Matisak P, Genge A, Guidon A, David W, Habib AA, Mathew V, Mozaffar T, Hinton JL, Hewitt W, Barnett D, Sullivan P, Ho D, Howard JF Jr, Traub RE, Chopra M, Kaminski HJ, Aly R, Bayat E, Abu-Rub M, Khan S, Lange D, Holzberg S, Khatri B, Lindman E, Olapo T, Sershon LM, Lisak RP, Bernitsas E, Jia K, Malik R, Lewis-Collins TD, Nicolle M, Nowak RJ, Sharma A, Roy B, Nye J, Pulley M, Berger A, Shabbir Y, Sachdev A, Patterson K, Siddiqi Z, Sivak M, Bratton J, Small G, Kohli A, Fetter M, Vu T, Lam L, Harvey B, Wolfe GI, Silvestri N, Patrick K, Zakalik K, Duda PW, MacDougall J, Farzaneh-Far R, Pontius A, Hoarty M. Howard JF Jr, et al. Among authors: david w. JAMA Neurol. 2020 May 1;77(5):582-592. doi: 10.1001/jamaneurol.2019.5125. JAMA Neurol. 2020. PMID: 32065623 Free PMC article. Clinical Trial.
Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis: Long-term Extension of RESILIENT.
Amato AA, Hanna MG, Machado PM, Badrising UA, Chinoy H, Benveniste O, Karanam AK, Wu M, Tankó LB, Schubert-Tennigkeit AA, Papanicolaou DA, Lloyd TE, Needham M, Liang C, Reardon KA, de Visser M, Ascherman DP, Barohn RJ, Dimachkie MM, Miller JAL, Kissel JT, Oskarsson B, Joyce NC, Van den Bergh P, Baets J, De Bleecker JL, Karam C, David WS, Mirabella M, Nations SP, Jung HH, Pegoraro E, Maggi L, Rodolico C, Filosto M, Shaibani AI, Sivakumar K, Goyal NA, Mori-Yoshimura M, Yamashita S, Suzuki N, Aoki M, Katsuno M, Morihata H, Murata K, Nodera H, Nishino I, Romano CD, Williams VSL, Vissing J, Zhang Auberson L; RESILIENT Study Extension Group. Amato AA, et al. Among authors: david ws. Neurology. 2021 Mar 23;96(12):e1595-e1607. doi: 10.1212/WNL.0000000000011626. Epub 2021 Feb 17. Neurology. 2021. PMID: 33597289 Free PMC article. Clinical Trial.
Hemoglobin variant in disguise.
Higgins V, MacNeil L, Sosova I, Ridsdale R, Bruce A, Brinc D, David W, Rara J, Bordeleau P, Estey MP, Parker ML, Ismail O, Agbor T. Higgins V, et al. Among authors: david w. Clin Biochem. 2023 Aug;118:110589. doi: 10.1016/j.clinbiochem.2023.110589. Epub 2023 May 24. Clin Biochem. 2023. PMID: 37236295
Hydrogen energy.
Edwards PP, Kuznetsov VL, David WI. Edwards PP, et al. Among authors: david wi. Philos Trans A Math Phys Eng Sci. 2007 Apr 15;365(1853):1043-56. doi: 10.1098/rsta.2006.1965. Philos Trans A Math Phys Eng Sci. 2007. PMID: 17272235 Review.
Neuromuscular Disorders.
David WS, Chad DA. David WS, et al. Semin Neurol. 2015 Aug;35(4):325. doi: 10.1055/s-0035-1558971. Epub 2015 Oct 6. Semin Neurol. 2015. PMID: 26502756 No abstract available.
Clozapine-induced myokymia.
David WS, Sharif AA. David WS, et al. Muscle Nerve. 1998 Jun;21(6):827-8. doi: 10.1002/(sici)1097-4598(199806)21:6<827::aid-mus22>3.0.co;2-o. Muscle Nerve. 1998. PMID: 9585344 No abstract available.
Inflammation in acquired hydrocephalus: pathogenic mechanisms and therapeutic targets.
Karimy JK, Reeves BC, Damisah E, Duy PQ, Antwi P, David W, Wang K, Schiff SJ, Limbrick DD Jr, Alper SL, Warf BC, Nedergaard M, Simard JM, Kahle KT. Karimy JK, et al. Among authors: david w. Nat Rev Neurol. 2020 May;16(5):285-296. doi: 10.1038/s41582-020-0321-y. Epub 2020 Mar 9. Nat Rev Neurol. 2020. PMID: 32152460 Free PMC article. Review.
283 results